Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

The vascular endothelin system in hypertension--recent patents and discoveries.

Hynynen MM, Khalil RA.

Recent Pat Cardiovasc Drug Discov. 2006 Jan;1(1):95-108. Review.

2.
3.

Endothelin, vascular hypertrophy, and hypertension.

Rosendorff C.

Cardiovasc Drugs Ther. 1997 Jan;10(6):795-802. Review.

PMID:
9110124
4.

Endothelin as a regulator of cardiovascular function in health and disease.

Haynes WG, Webb DJ.

J Hypertens. 1998 Aug;16(8):1081-98. Review.

PMID:
9794709
5.

Role of endothelin in the control of peripheral vascular tone in human hypertension.

Taddei S, Virdis A, Ghiadoni L, Sudano I, Magagna A, Salvetti A.

Heart Fail Rev. 2001 Dec;6(4):277-85. Review.

PMID:
11447302
6.

Highlights on endothelins: a review.

Ortega Mateo A, de Artiñano AA.

Pharmacol Res. 1997 Nov;36(5):339-51. Review.

PMID:
9441724
7.

Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease.

Mazzuca MQ, Khalil RA.

Biochem Pharmacol. 2012 Jul 15;84(2):147-62. doi: 10.1016/j.bcp.2012.03.020. Epub 2012 Mar 30. Review.

8.

Endothelin and endothelin antagonists: pharmacology and clinical implications.

Lüscher TF, Wenzel RR.

Agents Actions Suppl. 1995;45:237-53. Review.

PMID:
7717186
9.

Role of endothelin B receptors in enhancing endothelium-dependent nitric oxide-mediated vascular relaxation during high salt diet.

Giardina JB, Green GM, Rinewalt AN, Granger JP, Khalil RA.

Hypertension. 2001 Feb;37(2 Pt 2):516-23.

10.

Endothelin antagonists for hypertension and renal disease.

Barton M, Luscher TF.

Curr Opin Nephrol Hypertens. 1999 Sep;8(5):549-56. Review.

PMID:
10541216
11.

Endothelin: role in hypertension.

Schiffrin EL.

Biol Res. 1998;31(3):199-208. Review.

PMID:
9830507
12.

The role of endothelin in the vessel wall.

Chabrier PE.

Baillieres Clin Haematol. 1993 Sep;6(3):577-91. Review.

PMID:
8025344
13.

[Role of nitric oxide and other endothelium-derived factors].

Stankevicius E, Kevelaitis E, Vainorius E, Simonsen U.

Medicina (Kaunas). 2003;39(4):333-41. Review. Lithuanian.

14.

A critical review of the role of endothelial factors in the pathogenesis of hypertension.

Schiffrin EL.

J Cardiovasc Pharmacol. 2001 Nov;38 Suppl 2:S3-6. Review.

PMID:
11811373
15.

Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders.

Spieker LE, Noll G, Lüscher TF.

Am J Cardiovasc Drugs. 2001;1(4):293-303. Review.

PMID:
14728028
16.

Endothelin and endothelin antagonists: potential role in cardiovascular and renal disease.

Noll G, Wenzel RR, Lüscher TF.

Mol Cell Biochem. 1996 Apr 12-26;157(1-2):259-67. Review.

PMID:
8739256
17.

Endothelins as cardiovascular peptides.

Levin ER.

Am J Nephrol. 1996;16(3):246-51. Review.

PMID:
8739884
18.

Endothelin-1 and the regulation of vascular tone.

La M, Reid JJ.

Clin Exp Pharmacol Physiol. 1995 May;22(5):315-23. Review.

PMID:
7554421
19.

Role of endothelin in the cardiovascular system.

Rodríguez-Pascual F, Busnadiego O, Lagares D, Lamas S.

Pharmacol Res. 2011 Jun;63(6):463-72. doi: 10.1016/j.phrs.2011.01.014. Epub 2011 Feb 4. Review.

PMID:
21296157
20.

The clinical potential of endothelin receptor antagonists in cardiovascular medicine.

Ferro CJ, Webb DJ.

Drugs. 1996 Jan;51(1):12-27. Review.

PMID:
8741230

Supplemental Content

Support Center